As is shown in supplementary S1 Fig in keeping with our analyses, EphA2 is variably but significantly over-expressed on leukemias with t(11q23) MLL rearrangement compared to normal hematopoietic stem cells, early progenitor cells (HPCs), CMPs, MEPs and GMPs (P <0.0001). The gene discussed is KMT2A; the disease is leukemia.